These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12617105)

  • 1. Mechanisms of action of IVIg: physiology of Fc receptors.
    Reilly MP; McKenzie SE
    Vox Sang; 2002 Aug; 83 Suppl 1():57-63. PubMed ID: 12617105
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another interaction of the FcR system with IVIG.
    Bussel JB
    Thromb Haemost; 2002 Dec; 88(6):890-1. PubMed ID: 12529734
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose IVIG therapy in a child with idiopathic thrombocytopenic purpura associated with mumps.
    Buyukavci M; Yildirim ZK; Tan H
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):56-7. PubMed ID: 15654282
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of IVIG in ITP.
    Lazarus AH
    Vox Sang; 2002 Aug; 83 Suppl 1():53-5. PubMed ID: 12617104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of methotrexate to immunoglobulins kills macrophages by Fc receptor mediated uptake?
    Wang X; Yao C; Jiang Z
    Int J Lab Hematol; 2008 Jun; 30(3):185-90. PubMed ID: 18479295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
    Washburn N; Schwab I; Ortiz D; Bhatnagar N; Lansing JC; Medeiros A; Tyler S; Mekala D; Cochran E; Sarvaiya H; Garofalo K; Meccariello R; Meador JW; Rutitzky L; Schultes BC; Ling L; Avery W; Nimmerjahn F; Manning AM; Kaundinya GV; Bosques CJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1297-306. PubMed ID: 25733881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of anti-inflammatory activity of intravenous immunoglobulin via inhibitory Fcgamma receptors.
    Maródi L
    Pediatr Res; 2001 Nov; 50(5):551. PubMed ID: 11641444
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.
    Hansen RJ; Balthasar JP
    Thromb Haemost; 2002 Dec; 88(6):898-9. PubMed ID: 12529736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
    Imbach PA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopenia after bacille Calmette-Guerin immunization--possibly on an immune basis.
    Jakovljević G; Culić S
    Pediatr Hematol Oncol; 2007; 24(7):559-62. PubMed ID: 17786794
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
    Misra N; Bayry J; Ephrem A; Dasgupta S; Delignat S; Duong Van Huyen JP; Prost F; Lacroix-Desmazes S; Nicoletti A; Kazatchkine MD; Kaveri SV
    J Neurol; 2005 May; 252 Suppl 1():I1-6. PubMed ID: 15959666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune thrombocytopenic purpura after mumps infection.
    Unal S; Yetgin S; Kara A; Kanra G
    Turk J Pediatr; 2005; 47(3):270-1. PubMed ID: 16250314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.